These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21381495)

  • 1. Visfatin--a review.
    Sonoli SS; Shivprasad S; Prasad CV; Patil AB; Desai PB; Somannavar MS
    Eur Rev Med Pharmacol Sci; 2011 Jan; 15(1):9-14. PubMed ID: 21381495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nampt and its potential role in inflammation and type 2 diabetes.
    Garten A; Petzold S; Schuster S; Körner A; Kratzsch J; Kiess W
    Handb Exp Pharmacol; 2011; (203):147-64. PubMed ID: 21484571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visfatin/PBEF/Nampt: structure, regulation and potential function of a novel adipokine.
    Sommer G; Garten A; Petzold S; Beck-Sickinger AG; Blüher M; Stumvoll M; Fasshauer M
    Clin Sci (Lond); 2008 Jul; 115(1):13-23. PubMed ID: 19016657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyltransferase in adipose tissue with inflammation, insulin resistance, and plasma lipids.
    Chang YC; Chang TJ; Lee WJ; Chuang LM
    Metabolism; 2010 Jan; 59(1):93-9. PubMed ID: 19765775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease.
    Moschen AR; Geiger S; Gerner R; Tilg H
    Mutat Res; 2010 Aug; 690(1-2):95-101. PubMed ID: 19583971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity.
    Luk T; Malam Z; Marshall JC
    J Leukoc Biol; 2008 Apr; 83(4):804-16. PubMed ID: 18252866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases.
    Tilg H; Moschen AR
    Clin Sci (Lond); 2008 Feb; 114(4):275-88. PubMed ID: 18194136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of visfatin in the pathophysiology of human].
    Skoczylas A
    Wiad Lek; 2009; 62(3):190-6. PubMed ID: 20229717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma levels of PBEF/Nampt/visfatin are decreased in patients with liver cirrhosis.
    de Boer JF; Bahr MJ; Böker KH; Manns MP; Tietge UJ
    Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G196-201. PubMed ID: 19074645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visfatin/PBEF/Nampt and resistin expressions in circulating blood monocytes are differentially related to obesity and type 2 diabetes in humans.
    Laudes M; Oberhauser F; Schulte DM; Freude S; Bilkovski R; Mauer J; Rappl G; Abken H; Hahn M; Schulz O; Krone W
    Horm Metab Res; 2010 Apr; 42(4):268-73. PubMed ID: 20091460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like effects of visfatin on human osteoblasts.
    Xie H; Tang SY; Luo XH; Huang J; Cui RR; Yuan LQ; Zhou HD; Wu XP; Liao EY
    Calcif Tissue Int; 2007 Mar; 80(3):201-10. PubMed ID: 17340225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of visfatin gene polymorphisms on glycolipid metabolism and exercise-induced weight reduction in obesity].
    Lai AP; Chen WH
    Sheng Li Xue Bao; 2012 Feb; 64(1):96-100. PubMed ID: 22348967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinamide phosphoribosyl-transferase/visfatin: a missing link between overweight/obesity and postmenopausal breast cancer? Potential preventive and therapeutic perspectives and challenges.
    Dalamaga M
    Med Hypotheses; 2012 Nov; 79(5):617-21. PubMed ID: 22922056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinol-binding protein 4 and nicotinamide phosphoribosyltransferase/visfatin in rat obesity models.
    Mercader J; Granados N; Caimari A; Oliver P; Bonet ML; Palou A
    Horm Metab Res; 2008 Jul; 40(7):467-72. PubMed ID: 18401839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visfatin and cardio-cerebro-vascular disease.
    Wang P; Vanhoutte PM; Miao CY
    J Cardiovasc Pharmacol; 2012 Jan; 59(1):1-9. PubMed ID: 21266913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of visfatin/pre-B cell colony-enhancing factor 1/nicotinamide phosphoribosyltransferase, free and in complex with the anti-cancer agent FK-866.
    Kim MK; Lee JH; Kim H; Park SJ; Kim SH; Kang GB; Lee YS; Kim JB; Kim KK; Suh SW; Eom SH
    J Mol Biol; 2006 Sep; 362(1):66-77. PubMed ID: 16901503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of visfatin/PBEF/Nampt alters whole-body insulin sensitivity and lipid profile in rats.
    Sun Q; Li L; Li R; Yang M; Liu H; Nowicki MJ; Zong H; Xu J; Yang G
    Ann Med; 2009; 41(4):311-20. PubMed ID: 19263259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD.
    Axelsson J; Witasp A; Carrero JJ; Qureshi AR; Suliman ME; Heimbürger O; Bárány P; Lindholm B; Alvestrand A; Schalling M; Nordfors L; Stenvinkel P
    Am J Kidney Dis; 2007 Feb; 49(2):237-44. PubMed ID: 17261426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-B cell colony enhancing factor/NAMPT/visfatin in inflammation and obesity-related disorders.
    Moschen AR; Gerner RR; Tilg H
    Curr Pharm Des; 2010 Jun; 16(17):1913-20. PubMed ID: 20370672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visfatin is associated with lipid metabolic abnormalities in Lyon hypertensive rats.
    Wang P; Bai C; Xu QY; Xu TY; Su DF; Sassard J; Miao CY
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):894-9. PubMed ID: 20456420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.